AxwenBio is a Massachusetts-based biotechnology company.
The company works in two areas. One is peptide research and development. The other is Axelle, an online platform for prescription medicines for women in the United States.
We are building an innovative peptide therapeutics program for age-related disease. The molecules are our own designs; the targets are ones that approved medicines have already validated.
Axelle is a U.S. online platform for prescription medicines for women, operated by AxwenBio with independent physicians and licensed partner pharmacies.
Insights is our series on peptide science, written for researchers and others who work in the field.